In recent years, more and more international insurers have turned their attention to China's healthcare market. Taking high-value treatments such as oncology, orthopedics and cardiovascular care as examples, the cost of the same treatment plan at a Shanghai tertiary hospital is typically only 30% to 50% of that at comparable US or European providers, and some items are even lower. This significant cost difference has made "seeking treatment in China" an important option for the insurance industry in cost control and customer service upgrades.
Quality and safety are the biggest concerns of insurers. Shanghai has many JCI-accredited hospitals, including Ruijin Hospital, Huashan Hospital International Medical Center, and Shanghai Jiahui International Hospital. These institutions meet international standards in infection control, patient safety and medical processes. All are equipped with international medical departments or foreign-related services, provide multilingual support, and issue medical records and reports in both Chinese and English for easy claims review.
A professional service ecosystem has taken shape around medical travel: medical translation from $99/hour, professional accompaniment from $199/day, airport pickup $99/trip, post-operative follow-up $50/session, and free medical record structuring. Some hospitals have also established direct billing partnerships with 20+ international insurers, so clients do not need to advance large medical expenses.
For insurers and brokers, directing eligible clients to treatment in China not only significantly reduces claim amounts, but also improves customer loyalty and renewal rates through a high-quality medical experience. Medical tourism is upgrading from a "price advantage" to a "service value proposition", becoming a long-term strategy for cost reduction and efficiency improvement in the insurance industry.